ACADIA Pharma Shares Move Higher as JMP Boosted Price Target from $16 to $27
June 14, 2013 at 09:37 AM EDT
JMP Securities maintains ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) with a Market Outperform and raises the price target from $16.00 to $27.00. The stock has opened up more than 4 percent higher. With the stock last trading at $19.45, the firm's new price target implies potential upside of about 39
